Nasopharyngeal carcinomas: From biology to clinic;Les carcinomes du nasopharynx: De la biologie à la clinique

Cancer/Radiotherapie

Volumn 9, Issue 1, 2005, Pages 55-68

  Rivera, S ^a   Keryer, C ^b   Busson, P ^b   Maingon, P ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Concomitant radio chemotherapy; Epstein Barr virus; Intensity modulated radiotherapy; Nasopharyngeal carcinoma

Indexed keywords

BLEOMYCIN; CANCER VACCINE; CIDOFOVIR; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; PROTEIN; PROTEIN BLU; PROTEIN P16INK4A; PROTEIN P19; PROTEIN TYROSINE KINASE INHIBITOR; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; VINCRISTINE;

ADENOVIRUS; ALLELE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RELAPSE; CELL INFILTRATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DEMOGRAPHY; DIAGNOSTIC TEST; EPSTEIN BARR VIRUS; GENE DISRUPTION; GENE INACTIVATION; GENETIC DISORDER; HUMAN; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; METASTASIS; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SEROLOGY; VIRAL GENE THERAPY; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS LATENCY; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 15944366182     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2004.12.005     Document Type: Short Survey

References (119)

1. B. Abdulkarim, S. Sabri, D. Zelenika, E. Deutsch, V. Frascogna, and J. Klijanienko Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies Oncogene 22 2003 2260 2271
2. A. Ahmad, and S. Stefani Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients J. Surg. Oncol. 33 1986 194 197
3. M. Al-Sarraf, M. LeBlanc, P.G. Giri, K.K. Fu, J. Cooper, and T. Vuong Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J. Clin. Oncol. 16 1998 1310 1317
4. E. Au, E.H. Tan, and P.T. Ang Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer Ann. Oncol. 9 1998 327 329
5. M. Bachouchi, E. Cvitkovic, N. Azli, J. Gasmi, H. Cortes-Funes, and H. Boussen High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy J. Natl. Cancer Inst. 82 1990 616 620
6. A. Beck, D. Pazolt, G.G. Grabenbauer, J.M. Nicholls, H. Herbst, and L.S. Young Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease J. Pathol. 194 2001 145 151
7. J.M. Bedwinek, C.A. Perez, and D.J. Keys Analysis of failure after definitive irradiation for epidermoid carcinoma of the nasopharynx Cancer 45 1986 2725 2729
8. A.P. Brown, M. Urie, R. Chisin, H. Suit, and D. Phil Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning Int. J. Radiat. Oncol. Biol. Phys. 16 1989 1607 1614
9. P. Busson, G. Ganem, P. Flores, F. Mugneret, B. Clausse, and B. Caillou Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas Int. J. Cancer 42 1988 599 606
10. P. Busson, C. Keryer, T. Ooka, and M. Corbex EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies Trends Microbiol. 12 2004 356 360
11. A.T. Chan, P.M. Teo, T.W. Leung, and P.J. Johnson The role of chemotherapy in the management of nasopharyngeal carcinoma Cancer 82 1998 1003 1012
12. A.T. Chan, P.M. Teo, R.K. Ngan, T.W. Leung, W.H. Lau, and B. Zee Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial J. Clin. Oncol. 20 2002 2038 2044
13. J.T. Chang, L.C. See, S.G. Tang, S.P. Lee, C.C. Wang, and H.J. Hong The role of brachytherapy in early-stage nasopharyngeal carcinoma Int. J. Radiat. Oncol. Biol. Phys. 36 1996 1019 1024
14. F.M. Cheung, S.W. Pang, T.K. Yau, S.K. Chow, and K.W. Lo Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential Histopathology 45 2004 171 179
15. K.H. Chi, W.K. Chan, and D.L. Cooper A phase II study of outpatient chemotherapy with cisplatinium, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma Cancer 73 1994 247 252
16. K.H. Chi, Y. Chang, W. Guo, C. Shiau, L. Wang, and M. Hsu A phase III study of adjuvant chemotherapy in advanced stage nasopharyngeal carcinoma patients Int. J. Radiat. Oncol. Biol. Phys. 52 2002 1238 1244
17. V.F.H. Chong, and Y.F. Fan Skull base erosion in nasopharyngeal carcinoma: detection by CT and MRI Clin. Radiol. 51 1996 625 631
18. R. Choo, and I. Tannock Chemotherapy for recurent or metastatic carcinoma of the nasopharynx: a review of the Princes Margaret hospital experience Cancer 68 1991 2120 2124
19. L.S. Chow, K.W. Lo, J. Kwong, K.F. To, K.S. Tsang, and C.W. Lam RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma Int. J. Cancer 109 2004 839 947
20. D.T. Chua, J.M. Nicholls, J.S. Sham, and G.K. Au Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 59 2004 11 20
21. D.T. Chua, J.S. Sham, D.L. Kwong, and G.K. Au Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma Cancer 98 2003 74 80
22. T. Crook, J.M. Nicholls, L. Brooks, J. O'Nions, and M.J. Allday High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma Oncogene 19 2000 3439 3444
23. J. Daoud, and M. Frikha Carcinoma of the nasopharynx. Radiotherapy modalities and combined radiotherapy and chemotherapy: state of the art and perspectives Cancer Radiother. 5 2001 195s 200s
24. R. Dardari, M. Khyatti, H. Jouhadi, A. Benider, H. Ettayebi, and A. Kahlain Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma Int. J. Cancer 92 2001 294 297
25. G. Decaussin, F. Sbih-Lammali, M. de Turenne-Tessier, A. Bouguermouh, and T. Ooka Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies Cancer Res. 60 2000 5584 5588
26. F. De Vathaire, H. Sancho-Garnier, H. Dethe, C. Pieddeloup, G. Schwaab, and J.H. Ho Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study Int. J. Cancer 42 1988 176 181
27. R. Dolcetti, and J. Menezes Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: new immunobiological and molecular insights on a long-standing etiopathogenic association Adv. Cancer Res. 87 2003 127 157
28. J. Duraiswamy, M. Bharadwaj, J. Tellam, G. Connolly, L. Cooper, and D. Moss Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine Cancer Res. 64 2004 1483 1489
29. J. Duraiswamy, M. Sherritt, S. Thomson, J. Tellam, L. Cooper, and G. Connolly Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma Blood 101 2003 3150 3156
30. R.H. Edwards, F. Seillier-Moiseiwitsch, and N. Raab-Traub Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains Virology 261 1999 79 95
31. R.H. Edwards, D. Sitki-Green, D.T. Moore, and N. Raab-Traub Potential selection of LMP1 variants in nasopharyngeal carcinoma J. Virol. 78 2004 868 881
32. M.D. Eisen, D.M. Youssem, and T. Montone Use of preoperative MRI to predict dural, perineural and venous sinus invasion of skull base tumors AJNR Am. J. Neuroradiol. 17 1996 1937 1945
33. B.A. Erickson, and J.F. Wilson Nasopharyngeal brachytherapy Am. J. Clin. Oncol. 16 1993 424 443
34. F. Eschẁge, B. El Gueddari, and J. Bourhis Carcinomes du nasopharynx: aspects cliniques, indications et ŕsultats de la radioth́rapie transcutańe et de la curieth́rapie. Etat de la question en 2001 Cancer Radiother. 5 suppl1 2001 189s 194s
35. S. Faivre, F. Janot, and J.P. Armand Optimal management of nasopharyngeal carcinoma Curr. Opin. Oncol. 16 2004 231 235
36. A. Fandi, M. Altun, N. Azli, J.P. Armand, and E. Cvitkovic Nasopharyngeal cancer: epidemiology, staging and treatment Semin. Oncol. 21 1994 382 397
37. A. Fandi, M. Bachouchi, N. Azli, H. Boussen, P. Wibault, and F. Eschwege Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type J. Clin. Oncol. 18 2000 1324 1330
38. W. Fee, J.B. Robertson, and D.R. Goffinet Long-terme survival after surgical resection for recurrent nasopharyngeal cancer after radotherapy failure Arch. Otolaryngol. Head Neck Surg. 117 1991 1233 1236
39. B.J. Feng, W. Huang, Y.Y. Shugart, M.K. Lee, F. Zhang, and J.C. Xia Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4 Nat. Genet. 31 2002 395 399
40. W.H. Feng, B. Israel, N. Raab-Traub, P. Busson, and S.C. Kenney Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors Cancer Res. 62 2002 1920 1926
41. M. Frikha, M. Bouaziz, J. Daoud, A. Ghorbel, M. Ellouni, and M. Boudaya Evaluation de la ŕponse tumorale et ganglionnaire ̀ la chimioth́rapie ńo-adjuvante dans les carcinomes indiff́rencís du nasopharynx Bull. Cancer 84 1997 273 276
42. K. Fu Treatment of locally recurrent carcinoma of the nasopharynx Radiology 117 1975 425 431
43. D.R. Goffinet Treatment of recurrent NPC by radiation therapy in head and neck cancer Amsterdam: Experta medica 3 1993 155 164
44. V. Gŕgoire, P. Levendag, K.K. Ang, J. Bernier, M. Braaksma, and V. Budach CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG, consensus guidelines Radiother. Oncol. 69 2003 227 236
45. M.L. Gulley, J.M. Nicholls, B.G. Schneider, M.B. Amin, J.Y. Ro, and J. Geradts Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product Am. J. Pathol. 152 1998 865 869
46. N. Heussinger, M. Buttner, G. Ott, E. Brachtel, B.Z. Pilch, and E. Kremmer Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma J. Pathol. 203 2004 696 699
47. R. Hirunsatit, N. Kongruttanachok, K. Shotelersuk, P. Supiyaphun, N. Voravud, and A. Sakuntabhai Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer BMC Genet. 4 2003 3
48. J.H. Ho Stage classification of nasopharyngeal carcinoma:: a review IARC Sci. Publ. 20 1978 99 113
49. R.L. Hong, C.Y. Lin, L.L. Ting, J.Y. Ko, and M.M. Hsu Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA Cancer 100 2004 1429 1437
50. Hu LFH. Q. Fu, S. Di, S. Magnusson, K. Ernberg, I. Possible linkage of susceptibility genes of nasopharyngeal carcinoma to chromosome 5. In: North-South Workshop on Nasopharyngeal Carcinoma; 2003; Institut Gustave Roussy, Villejuif, France.
51. S.C. Huang, L.T. Lui, and T.C. Lynn Nasopharyngeal cancer:: study III. A review of 1206 patients treated with combined modalities Int. J. Radiat. Oncol. Biol. Phys. 1 1985 1789 1793
52. Y.T. Huang, T.S. Sheen, C.L. Chen, J. Lu, Y. Chang, and J.Y. Chen Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells Cancer Res. 59 1999 1599 1605
53. A.B. Hui, K.W. Lo, J. Kwong, E.C. Lam, S.Y. Chan, and L.S. Chow Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma Mol. Carcinog. 38 2003 170 178
54. M.A. Hunt, M.J. Zelefsky, S. Wolden, C.S. Chui, T. LoSasso, and Rosenzweig Treatment planning and delivery of intensity-modulatedradiation therapy for primary nasopharynx cancer Int J Radiat Oncol Biol Phys 49 2001 623 632
55. International nasopharynx cancer study group Preliminary results of a randomized trial comparing neoadjuvant chemotherapy plus radiotherapy versus radiotherapy alone in stage IV (N2-N3 M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. VUMCA I trial Int J Radiat Oncol Biol Phys 35 1996 463 469
56. M. Jalbout, N. Bouaouina, J. Gargouri, M. Corbex, S. Ben Ahmed, and L. Chouchane Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma Cancer Lett. 193 2003 75 81
57. D.B.G. Jeannel, and A. Hubert Nasopharyngeal Carcinoma: An Epidemiological Approach to Carcinogensis Cancer Surv. 33 1999 125 155
58. Y.K. Jeon, B.Y. Lee, J.E. Kim, S.S. Lee, and C.W. Kim Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea Head Neck 26 2004 573 583
59. S. Kaasa, E. Kragh-Jensen, K. Bjordal, E. Lund, J.F. Evensen, and H. Vermund Prognostic factors in patients with nasopharyngeal carcinoma Acta Oncol. 32 1993 531 536
60. M.K. Kam, R.M. Chau, J. Suen, P.H. Choi, and P.M. Teo Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation Int. J. Radiat. Oncol. Biol. Phys. 56 2003 145 157
61. C.H. Kao, J.F. Hsieh, S.C. Tsai, Y.J. Ho, R.F. Yen, and S.P. Chang Lai Comparision of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detectiion of cervical lymph node metastases of nasopharyngeal carcinoma Ann Otol Rhinol Laryngol 109 2000 1130 1134
62. A. Khabir, A. Ghorbel, J. Daoud, M. Frikha, M.M. Drira, and A. Laplanche Similar BCL-X but different BCL-2 levels in the two age groups of north African nasopharyngeal carcinomas Cancer Detect. Prev. 27 2003 250 255
63. A. Khabir, A. Sellami, M. Sakka, A.M. Ghorbel, J. Daoud, and M. Frikha Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas Clin. Cancer Res. 6 2000 3932 3936
64. R. Khanna, P. Busson, S.R. Burrows, C. Raffoux, D.J. Moss, and J.M. Nicholls Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells Cancer Res. 58 1998 310 314
65. S. Kripalani-Joshi, and H.Y. Law Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis Int. J. Cancer 56 1994 187 192
66. N. Lee, P. Xia, J.M. Quivey, K. Sultanem, I. Poon, and P. Akazawa Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 2002 1 3
67. S. Leibel, G. Kutcher, and L. Harrison Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx Int. J. Radiat. Oncol. Biol. Phys. 20 1991 823 833
68. J.H. Li, W. Shi, M. Chia, O. Sanchez-Sweatman, C. Siatskas, and D. Huang Efficacy of targeted FasL in nasopharyngeal carcinoma Mol. Ther. 8 2003 964 973
69. C.L. Lin, W.F. Lo, T.H. Lee, Y. Ren, S.L. Hwang, and Y.F. Cheng Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma Cancer Res. 62 2002 6952 6958
70. J.C. Lin, J.S. Jan, C.Y. Hsu, W.M. Liang, R.S. Jiang, and W.Y. Wang Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J. Clin. Oncol. 21 2003 631 637
71. R. Lin, J.D. Slater, L.T. Yonemoto, R.I. Grove, S.L. Teichman, and D.K. Watt Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy dose volume histogram analysis Radiology 213 1999 489 494
72. S.H. Liu, J.T. Chang, S.H. Ng, S.C. Chan, and T.C. Yen False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient Br. J. Radiol. 77 2004 257 260
73. X.Q. Liu, H.K. Chen, X.S. Zhang, Z.G. Pan, A. Li, and Q.S. Feng Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma Int. J. Cancer 106 2003 60 65
74. K.W. Lo, and D.P. Huang Genetic and epigenetic changes in nasopharyngeal carcinoma Semin. Cancer Biol. 12 2002 451 462
75. J.J. Lu, T.P. Shakespeare, L.K. Tan, B.C. Goh, and J.S. Cooper Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in T1 and T2 nasopharyngeal carcinoma Head Neck 26 2004 389 395
76. T.X. Lu, W.Y. Mai, B.S. Teh, C. Zhao, F. Han, and Y. Huang Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma Int. J. Radiat. Oncol. Biol. Phys. 58 2004 682 687
77. B.B. Ma, I.F. Tannock, G.R. Pond, M.R. Edmonds, and L.L. Siu Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma Cancer 95 2002 2516 2523
78. J. Ma, H.Q. Mai, M.H. Hong, H.Q. Min, Z.D. Mao, and N.J. Cui Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J. Clin. Oncol. 19 2001 1350 1357
79. N. Mokni-Baizig, K. Ayed, F.B. Ayed, S. Ayed, F. Sassi, and A. Ladgham Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia Oncology 61 2001 55 58
80. S. Murono, N. Raab-Traub, and J.S. Pagano Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs Cancer Res. 61 2001 7875 7877
81. A. Nanbo, K. Inoue, K. Adachi-Takasawa, and K. Takada Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma EMBO J. 21 2002 954 965
82. H.B. Neel, and W.F. Taylor New staging system for nasopharyngeal carcinoma Arch. Otolaryngol. Head Neck Surg. 115 1989 1293 1303
83. S.H. Ng, J.T. Chang, S.C. Chan, S.F. Ko, H.M. Wang, and C.T. Liao Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET Eur. J. Nucl. Med. Mol. Imaging 31 2004 1073 1080
84. J. Nicholls, P. Hahn, E. Kremmer, T. Frohlich, G.J. Arnold, and J. Sham Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material J. Virol. Methods 116 2004 79 88
85. J.M. Nicholls, A. Agathanggelou, K. Fung, X. Zeng, and G. Niedobitek The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma J. Pathol. 183 1997 164 168
86. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int. J. Cancer 94 2001 153 156
87. C.A. Perez, V.R. Devineni, V. Marcial-Vega, J.E. Marks, J.R. Simpson, and N. Kucik Carcinoma of the nasopharynx:: Factors affecting prognosis Int. J. Radiat. Oncol. Biol. Phys. 23 1992 271 280
88. R. Prizant, and C. Wendt Retreatment of NPC in 53 patients Int J Radiat Oncol Biol Phys 22 1992 941 947
89. C.N. Qian, X. Guo, B. Cao, E.J. Kort, C.C. Lee, and J. Chen Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma Cancer Res. 62 2002 589 596
90. D. Qin, Y. Hu, J. Yan, G. Xu, W. Cai, and X. Wu Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation Cancer 61 1988 1117 1124
91. N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC Semin. Cancer Biol. 12 2002 431 441
92. S.K. Rodriguez, A. Keryer, C. Drira, M. Ghorbel, A. Jlidi, and R. Bernehiem Conventional and array-based CGH analysis of Nasopharyngeal Carcinomas from the Mediterranean area: high frequency of gains at 1q and 12p and losses at 11q and 13q 2005 Cancer Genetics and Cytogenetics (sous presse)
93. A. Rossi, R. Molinari, P. Borrachi, M. Del Vecchio, E. Marubini, and M. Nava Adjuvant chemotherapy with vincristine, cyclophosphamide and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer results of a 4-years multicenter randomized study J. Clin. Oncol. 58 1988 1401 1410
94. F. Sbih-Lammali, B. Clausse, H. Ardila-Osorio, R. Guerry, M. Talbot, and S. Havouis Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation Cancer Res. 59 1999 924 930
95. U. Schaefer, O. Micke, P. Schueller, and N. Willich Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study Radiology 216 2000 371 376
96. G. Schwaab, C. Micheau, F. Eschẁge, and D. Lengrand Les carcinomes du nasopharynx: Etude anatomo-clinique, clinique, traitement, ŕsultats Lemerle 1993 Masson Paris 88 89
97. J.S.T. Sham, Y.K. Cheung, F.L. Chan, and D. Choy Nasopharyngeal carcinoma: pattern of skeletal metastases Br. J. Radiol. 63 1990 202 205
98. S.S. Shin, Y.C. Ahn, H. Lim do, W. Park, and S.J. Huh High dose 3-dimensional re-irradiation for locally recurrent nasopharyngeal cancer Yonsei Med. J. 29 2004 100 106
99. N.J. Slevin, J.M. Wilkinson, H.M. Filby, and N.K. Gupta Intracavitary radiotherapy boosting for nasopharyngeal cancer Br. J. Radiol. 70 1997 412 414
100. W.C. Su, T.Y. Chen, R.H. Kao, and C.J. Tsao Chemotherapy with platin and continous infusion of 5-fluorouracil and bĺomycin for recurrent and metastatic nasopharyngeal carcinoma in Taïwan Oncology 50 1993 205 208
101. A. Taamma, A. Fandi, N. Azli, P. Wibault, N. Chouaki, and A. Hasbini Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin and cisplatin for locally advanced and metastatic/recurrent undifferenciated carcinoma of the nasopharynx type Cancer 86 1999 1101 1108
102. K.F. Tang, S.Y. Tan, S.H. Chan, S.M. Chong, K.S. Loh, and L.K. Tan A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages Hum. Pathol. 32 2001 42 49
103. P.M. Teo, and A.T. Chan Treatment strategy and clinical experience Semin. Cancer Biol. 12 2002 497 504
104. P.M. Teo, S.F. Leung, W.Y. Lee, and B. Zee Intracavitary brachytherapy significantly enhances local control of early T stage nasopharyngeal carcinoma: the existenceof a dose-tumor-control relationship above conventional tumoricidal dose Int. J. Radiat. Oncol. Biol. Phys. 46 2000 445 458
105. TNM Classification of malignant tumors 2003 Sixth Edition. UICC 33 37 Tsuji H, et al. Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy. Cancer 1989;63:1668-72
106. S.W. Tsao, G. Tramoutanis, C.W. Dawson, A.K. Lo, and D.P. Huang The significance of LMP1 expression in nasopharyngeal carcinoma Semin. Cancer Biol. 12 2002 473 487
107. H. Tsuji, T. Kamada, H. Tsuji, A. Takamura, Y. Matsuoka, and H. Usubichi Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy Cancer 63 1989 1668 1672
108. G. Tu, Y. Hu, and N. Ye Salvage surgery for nasopharyngeal carcinoma Arch. Otolaryngol. Head Neck Surg. 114 1988 328 329
109. C.C. Wang Re-irradiation of recurrent nasopharyngeal carcinoma treatment techniques and results Int. J. Radiat. Oncol. Biol. Phys. 13 1987 953 956
110. C.C. Wang Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results Cancer 63 1989 2461 2467
111. S.L. Wolden, M.J. Zelefsky, M.A. Hunt, K.E. Rosenzweig, L.M. Chong, and D.H. Kraus Failure of 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1229 1234
112. Z.W. Wong, E.H. Tan, S.P. Yap, T. Tan, S.S. Leong, and K.W. Fong Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma Head Neck 24 2002 549 554
113. World Health Organisation WHO handbook for reporting results of cancer treatment 1979 WHO Offset publication Geneva 48
114. Q. Wu, M. Manning, R. Schmidt-Ullrich, and R. Mohan The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study Int. J. Radiat. Oncol. Biol. Phys. 46 2000 195 205
115. W. Xiong, Z.Y. Zeng, J.H. Xia, K. Xia, S.R. Shen, and X.L. Li A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma Cancer Res. 64 2004 1972 1974
116. J.H. Yan, Y.H. Hu, and X.Z. Gu Radiation therapy of recurrent nasopharyngeal carcinoma: Report of 219 patients Acta Radiol. Oncol. 22 1983 23 29
117. R.F. Yen, R.L. Hung, M.H. Pan, Y.H. Wang, K.M. Huang, and L.T. Lui 18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging Cancer 98 2003 283 287
118. M.C. Yu, and J.M. Yuan Epidemiology of nasopharyngeal carcinoma Semin. Cancer Biol. 12 2002 421 429
119. J.X. Zhang, H.L. Chen, Y.S. Zong, K.H. Chan, J. Nicholls, and J.M. Middeldorp Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma J. Med. Virol. 55 1998 227 233